Statistics

Total Visits

Views
A phase II study of capecitabine in combination with erlotinib as first-line therapy in patients with metastatic pancreatic cancer (stage IV)99

Select a period of time:

Number of views in the range

Views
A phase II study of capecitabine in combination with erlotinib as first-line therapy in patients with metastatic pancreatic cancer (stage IV)39

Views

Views
May 20254
June 20255
July 202519
August 20252
September 20252
October 20253
November 20254
Download CSV file
 untranslated
 untranslated

Top country views

Views
United States17
Brazil14
United Kingdom6
Paraguay1
Trinidad and Tobago1
 

Top cities views

Views
Santa Maria2
Chicago2
Ashburn1
Barra Bonita1
Barra do Piraí1
Caraúbas1
Carutapera1
Chaguanas1
Cincinnati1
Dallas1